I believe that it was double digit originally but that was only specific to a particular treatment/use of TA.
My understanding was that it was then re-negotiated down into single digits when the license was expanded into a usage/treatment within a much bigger market.
For this deal with Oculus, wouldn't the license to Alcon need to be novated? If this is the case, wouldn't Alcon need to agree? Maybe this has highlighted the value of the Alcon royalities to other parties who like the IP.
- Forums
- ASX - By Stock
- someone please help
AOS
advanced ocular systems limited
I believe that it was double digit originally but that was only...
-
- There are more pages in this discussion • 4 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)